• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1996 Fiscal Year Final Research Report Summary

Studies on adjuvant therapies for prevention of hepatic matastasis after resection of pancreatic cancer

Research Project

Project/Area Number 06454378
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionUniversity of Tsukuba

Principal Investigator

FUKAO Katashi  University of Tsukuba, Department of Surgery, Professor, 臨床医学系, 教授 (50091921)

Co-Investigator(Kenkyū-buntansha) ODA Tatsuya  University of Tsukuba, Department of Surgery, Assistant Professor, 臨床医学系, 講師 (20282353)
ISHIKAWA Akio  University of Tsukuba, Department of Surgery, Assistant Professor, 臨床医学系, 助教授 (50134226)
OHARA Kiyoshi  University of Tsukuba, Department of Radiology, Assistant Professor, 臨床医学系, 助教授 (10034125)
Project Period (FY) 1994 – 1996
KeywordsPancreatic carcinoma / liver metastasis / ostoperative recurrence / preoperative radiation therapy / adjubant therapy / liver function assay test / E-cadherin
Research Abstract

Postoperative course of the patient with Pancreatic carcinoma is in sufficient, because of the frequent presentation of liver metastasis. Combination of operation and adjuband therapy is only the way for improving the prognosis, however, morbidity and mortality rate may increase. In order to clarify the safes of pancreatico duodenectomy (PD), when radiation therapy is added, and/or the molecular mechanisms of liver metastasis, following issues were analyzed. (1) Because anatomy of eliminatory tract of monkey is similar to those of human, PD for monkey should be a useful model to know and evaluate the in fluence of pre-, intea- and post-operative radiation therapy. We have established the standard PD technique for monkey. (2) We clinically applied liver function assay test, using Trimethadione, for the preoperative patient of PD.(3) Intending to know the molecular mechanisms of liver metastasis, twenty-eight primary pancreatic carcinomas and liver metastatic nodules from 16 or them were analyzed for E-cadherin (E-cad) and alpha-catenin (alpha-cat) protein expression. We found that the status of the E-cad and alpha-cat expression has no significant predictive value, even though there seem to be a higher tendency to liver metastasis for cases with integrity of such cell-cell interaction system.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Kiyoshi OHARA: "Impact of biologieal clearance on tumor radiorespansivne" Int.J.Radiation Oncology. 34(2). 389-393 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kiyosi OHARA: "Clearance of parenchymal tumors following radiotherapy." Radi otherapy and Oncology. 41. 233-236 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Akio Isikawa: "Trimethadione as a Probe Drug to Estimate Hepatic Oxidizing CapHU" Comp.Biochem,Physiol,. 115C(3). 211-216 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 石川 詔雄: "SIRS関連酵素に対するプロテアーゼインヒビター阻害機構について" Progress in medicine. 16(9). 2161-2166 (1996)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ohara K et.al.: "Impact of biological clearance on tumor radioresponsiveness." Int J Radiat Oncol Biol Phys. 34(2). 389-93 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ohara K et.al.: "Clearance of parenchymal tumors following radiotherapy." Radiotherapy and Oncology.41. 233-236 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishikawa A et.al.: "Trimethadione as a probe drug to estimate hepatic oxidizing capacity in human." Comp.Biochem.Physiol.16(9). 211-216 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishikawa A.: "Inhibition mechanisms of Protease-inhibitor for SIRS related enzymes. (in Japanese)" Progress in Medicine. 16(9). 2161-2166 (1996)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi